Form 4 for BRKR BRUKER CORP
Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-02 · accession 0001179110-21-008582 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-03 | 2021-09-02 | BRKR | Srega Juergen | Group Pres Bruker CALID | M - OptEx | $19.84 | +190.3K | 258.2K | +280% | +$3.77M |
| D | 2021-09-03 | 2021-09-02 | BRKR | Srega Juergen | Group Pres Bruker CALID | S - Sale+OE | $89.54 | -202.2K | 130.9K | -61% | -$18.11M |
| DM | 2021-09-03 | 2021-09-02 | BRKR | Srega Juergen | Group Pres Bruker CALID | M - OptEx | $0.00 | -190.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-02 | M | A | 90,000 | $18.57 | 232,877 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-02 | S | D | 202,216 | $89.54 | 130,936 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.5014 to $90.15, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2021-09-02 | M | A | 35,438 | $19.82 | 293,684 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-02 | M | A | 39,468 | $22.19 | 333,152 | D | — | — | |
| 5 | Common | Common Stock | 2021-09-02 | M | A | 25,369 | $20.68 | 258,246 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Purchase) | 2021-09-02 | M | D | 90,000 | $0.00 | 0 | D | $18.57 · — to 2023-04-03 | 90,000 Common Stock | (F1) The stock option granted to the Reporting Person on April 3, 2013 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |
| 7 | Derivative | Stock Option (Right to Purchase) | 2021-09-02 | M | D | 35,438 | $0.00 | 0 | D | $19.82 · — to 2025-08-07 | 35,438 Common Stock | (F3) The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |
| 8 | Derivative | Stock Option (Right to Purchase) | 2021-09-02 | M | D | 39,468 | $0.00 | 0 | D | $22.19 · — to 2026-10-04 | 39,468 Common Stock | (F4) The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |
| 9 | Derivative | Stock Option (Right to Purchase) | 2021-09-02 | M | D | 25,369 | $0.00 | 0 | D | $20.68 · — to 2024-08-08 | 25,369 Common Stock | (F2) The stock option granted to the Reporting Person on August 8, 2014 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |